Cargando…

Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes

Cuproptosis is a newly discovered type of cell death triggered by copper accumulation. Here we exhibited the genetic profiles of 10 cuproptosis-associated genes (CuAGs) across 21 cancer types. Only 8.0% (627/7839) of tumors possessed at least 1 mutation on CuAGs, while the copy number amplifications...

Descripción completa

Detalles Bibliográficos
Autores principales: Bu, Fanqin, Li, Xiangji, Zhao, Yu, Bai, Liyi, Zhang, Shutian, Min, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887831/
https://www.ncbi.nlm.nih.gov/pubmed/36721175
http://dx.doi.org/10.1186/s40364-022-00446-5
_version_ 1784880416051691520
author Bu, Fanqin
Li, Xiangji
Zhao, Yu
Bai, Liyi
Zhang, Shutian
Min, Li
author_facet Bu, Fanqin
Li, Xiangji
Zhao, Yu
Bai, Liyi
Zhang, Shutian
Min, Li
author_sort Bu, Fanqin
collection PubMed
description Cuproptosis is a newly discovered type of cell death triggered by copper accumulation. Here we exhibited the genetic profiles of 10 cuproptosis-associated genes (CuAGs) across 21 cancer types. Only 8.0% (627/7839) of tumors possessed at least 1 mutation on CuAGs, while the copy number amplifications or deletions on the alleles of CuAGs were ubiquitous. Generally, the expression of CuAGs showed heterogeneity across cancer types and the expression of CuAGs showed different correlations with MSI, TMB, immune and stromal features in different cancer types. Therefore, CuAGs were ubiquitously and heterogeneously dysregulated in pan-cancer. With a Non-negative Matrix Factorization method, we divided patients of each cancer type into cuproptosis-based subtypes, which showed a close but heterogeneous correlation with different biological and clinical features. Accordingly, we summarized all cancer types into four categories. The cancers in which cuproptosis subtypes correlated with MSI and TMB were annotated as Genomic disturbed. Those correlated with stromal scores were categorized as Stromal remolded. The others only associated with immune infiltration were labeled as Immune inhibited. A minor fraction of cancers not correlated with any biological indicators were marked as Cuproptosis inert. Together, we provided a pan-cancer overview of cuproptosis markers which revealed biologically and clinically relevant cancer subtypes in different cancers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40364-022-00446-5.
format Online
Article
Text
id pubmed-9887831
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98878312023-02-01 Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes Bu, Fanqin Li, Xiangji Zhao, Yu Bai, Liyi Zhang, Shutian Min, Li Biomark Res Correspondence Cuproptosis is a newly discovered type of cell death triggered by copper accumulation. Here we exhibited the genetic profiles of 10 cuproptosis-associated genes (CuAGs) across 21 cancer types. Only 8.0% (627/7839) of tumors possessed at least 1 mutation on CuAGs, while the copy number amplifications or deletions on the alleles of CuAGs were ubiquitous. Generally, the expression of CuAGs showed heterogeneity across cancer types and the expression of CuAGs showed different correlations with MSI, TMB, immune and stromal features in different cancer types. Therefore, CuAGs were ubiquitously and heterogeneously dysregulated in pan-cancer. With a Non-negative Matrix Factorization method, we divided patients of each cancer type into cuproptosis-based subtypes, which showed a close but heterogeneous correlation with different biological and clinical features. Accordingly, we summarized all cancer types into four categories. The cancers in which cuproptosis subtypes correlated with MSI and TMB were annotated as Genomic disturbed. Those correlated with stromal scores were categorized as Stromal remolded. The others only associated with immune infiltration were labeled as Immune inhibited. A minor fraction of cancers not correlated with any biological indicators were marked as Cuproptosis inert. Together, we provided a pan-cancer overview of cuproptosis markers which revealed biologically and clinically relevant cancer subtypes in different cancers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40364-022-00446-5. BioMed Central 2023-01-31 /pmc/articles/PMC9887831/ /pubmed/36721175 http://dx.doi.org/10.1186/s40364-022-00446-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correspondence
Bu, Fanqin
Li, Xiangji
Zhao, Yu
Bai, Liyi
Zhang, Shutian
Min, Li
Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes
title Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes
title_full Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes
title_fullStr Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes
title_full_unstemmed Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes
title_short Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes
title_sort pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887831/
https://www.ncbi.nlm.nih.gov/pubmed/36721175
http://dx.doi.org/10.1186/s40364-022-00446-5
work_keys_str_mv AT bufanqin pancancerpatternsofcuproptosismarkersrevealbiologicallyandclinicallyrelevantcancersubtypes
AT lixiangji pancancerpatternsofcuproptosismarkersrevealbiologicallyandclinicallyrelevantcancersubtypes
AT zhaoyu pancancerpatternsofcuproptosismarkersrevealbiologicallyandclinicallyrelevantcancersubtypes
AT bailiyi pancancerpatternsofcuproptosismarkersrevealbiologicallyandclinicallyrelevantcancersubtypes
AT zhangshutian pancancerpatternsofcuproptosismarkersrevealbiologicallyandclinicallyrelevantcancersubtypes
AT minli pancancerpatternsofcuproptosismarkersrevealbiologicallyandclinicallyrelevantcancersubtypes